These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28540143)

  • 1. Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical Perspective.
    Malik R; Mushtaque RS; Siddiqui UA; Younus A; Aziz MA; Humayun C; Mansoor K; Latif MA; Waheed S; Assad S; Khan I; Bukhari SM; DelCampo D; Adus A; Gannarapu S
    Cureus; 2017 Apr; 9(4):e1188. PubMed ID: 28540143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
    Kanuri SH; Ipe J; Kassab K; Gao H; Liu Y; Skaar TC; Kreutz RP
    Atherosclerosis; 2018 Nov; 278():232-239. PubMed ID: 30336307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNA as a Biomarker for Coronary Artery Disease.
    Fazmin IT; Achercouk Z; Edling CE; Said A; Jeevaratnam K
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32977454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-146a and miRNA-126 as Potential Biomarkers in Patients with Coronary Artery Disease and Generalized Periodontitis.
    Mahendra J; Mahendra L; Fageeh HN; Fageeh HI; Ibraheem W; Abdulkarim HH; Kanakamedala A; Prakash P; Srinivasan S; Balaji TM; Varadarajan S; Jagannathan R; Patil S
    Materials (Basel); 2021 Aug; 14(16):. PubMed ID: 34443215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
    Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
    PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease.
    Zhang L; Zhang Y; Zhao Y; Wang Y; Ding H; Xue S; Li P
    Expert Opin Ther Pat; 2018 Aug; 28(8):591-601. PubMed ID: 30064285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
    Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
    Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
    Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.
    Trusinskis K; Lapsovs M; Paeglite S; Knoka E; Caunite L; Mazule M; Briede I; Jegere S; Kumsars I; Narbute I; Konrade I; Erglis A; Lejnieks A
    J Clin Transl Res; 2021 Apr; 7(2):270-276. PubMed ID: 34104831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.
    Stratz C; Nührenberg T; Fiebich BL; Amann M; Kumar A; Binder H; Hoffmann I; Valina C; Hochholzer W; Trenk D; Neumann FJ
    Thromb Haemost; 2014 May; 111(5):902-11. PubMed ID: 24352417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.
    Satoh M; Takahashi Y; Tabuchi T; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Apr; 128(8):483-91. PubMed ID: 25385173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension-A Systematic Review.
    Kondracki B; Kłoda M; Jusiak-Kłoda A; Kondracka A; Waciński J; Waciński P
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
    Schulte C; Molz S; Appelbaum S; Karakas M; Ojeda F; Lau DM; Hartmann T; Lackner KJ; Westermann D; Schnabel RB; Blankenberg S; Zeller T
    PLoS One; 2015; 10(12):e0145930. PubMed ID: 26720041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.
    Wong RJ; Kanwal F; Younossi ZM; Ahmed A
    Dig Dis Sci; 2014 Jul; 59(7):1586-93. PubMed ID: 24894512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery disease: Are men and women created equal?
    Blum A; Blum N
    Gend Med; 2009 Sep; 6(3):410-8. PubMed ID: 19850237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI.
    O Sullivan JF; Neylon A; McGorrian C; Blake GJ
    Int J Cardiol; 2016 Dec; 224():310-316. PubMed ID: 27665403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts.
    Schulte C; Zeller T
    Cardiovasc Diagn Ther; 2015 Feb; 5(1):17-36. PubMed ID: 25774345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.